Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |